Effective Cancer Management: Inimitable Role of Phytochemical Based Nano- Formulations.
| Autor: | Upaganlawar A; SNJBs SSDJ College of Pharmacy, Neminagar, Chandwad, Maharashtra, India., Polshettiwar S; School of Pharmacy Dr.Vishwanath Karad MIT World Peace University, Survey No. 124, Kothrud, Pune, Maharashtra 411038, India., Raut S; Dr. D. Y. Patil Institute of Pharmaceutical Sciences and Research, Pimpri, Pune-India., Tagalpallewar A; School of Pharmacy Dr.Vishwanath Karad MIT World Peace University, Survey No. 124, Kothrud, Pune, Maharashtra 411038, India., Pande V; N. N. Sattha College of Pharmacy, Ahmednagar, Maharashtra, India. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Current drug metabolism [Curr Drug Metab] 2022; Vol. 23 (11), pp. 869-881. |
| DOI: | 10.2174/1389200223666220905162245 |
| Abstrakt: | Background: Global cancer statistics defines the severity of disease even after significant research worldwide. Problem: Failure of the currently available treatment approaches, including surgery, radiation therapy and traditional chemotherapy. Aim: The aim of this review is to discuss the role of phytochemical based nano-formulations for treatment of cancer. Discussion: In the past few decades, phytochemicals have gained popularity for acting as a potential anticancer treatment with low systemic toxicity, especially in terms of cell cycle control and cancer cell killing. Natural resources, with their immense structural variety, serve as a vital source of fresh, therapeutically useful new chemical entities for the treatment of cancer. Vinca alkaloids (VCR), vinblastine, vindesine, vinorelbine, taxanes (PTX), podophyllotoxin and its derivatives (etoposide (ETP), teniposide, camptothecin (CPT) and its derivatives (topotecan, irinotecan), anthracyclines (doxorubicin, daunorubicin, epirubicin, idarubicin, as natural products or their derivatives account for half of all anticancer drugs approved worldwide, and they have been developed utilising the knowledge learned from the natural small molecules or macromolecules. Trabectedin, an epothilone derivative, ixabepilone, and temsirolimus, three new anticancer medications launched in 2007, were derived from microbial origins. Current therapy regimens require selective drug targeting to enhance efficacy against cancer cells while normal cells remain unharmed. Modified medications and systems for drug delivery based on nanotechnology are in the process of being explored and launched in the industry for enhanced therapy and management of cancer, along with promising outcomes. Many obstacles related to cancer cell drug delivery can be overcome by using nano-particulate drug carriers, including enhancing the stability and solubility of the drug, prolonging half-lives of the drug in the blood, decreasing side effects to undesired organs, and increasing medication concentration at the desired site. The scientific initiatives and studies concerning the use of nanotechnology for some selective compounds derived from plants are discussed in this review article. Conclusion: The present review highlights the phytochemical-based nanoformulations and their strategies in the development of novel systems of drug delivery such as nano-liposomes, functionalized nanoparticles (NPs), and polymer nano-conjugates, SNEDDS (Self nano emulsifying drug delivery system) as this review paper depicts, as well as their rewards over conventional systems of drug delivery, as evidenced by improved biological activity depicted in their in vitro and in vivo anticancer assays. (Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|